Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis

被引:6
|
作者
Hubl, Daniela [1 ]
Michel, Chantal [2 ]
Schultze-Lutter, Frauke [3 ]
Hauf, Martinus [4 ]
Schimmelmann, Benno G. [2 ,5 ]
Kaess, Michael [2 ,6 ]
Kindler, Jochen [2 ]
机构
[1] Univ Bern, Univ Hosp Psychiat & Psychotherapy, Translat Res Ctr, Bern, Switzerland
[2] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland
[3] Heinrich Heine Univ, Med Fac, Dept Psychiat & Psychotherapy, Dusseldorf, Germany
[4] Univ Bern, Support Ctr Adv Neuroimaging SCAN, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland
[5] Univ Hosp Hamburg Eppendorf, Univ Hosp Child & Adolescent Psychiat, Hamburg, Germany
[6] Univ Hosp Heidelberg, Ctr Psychosocial Med, Dept Child & Adolescent Psychiat, Sect Translat Psychobiol Child & Adolescent Psych, Heidelberg, Germany
关键词
Basic symptoms; first-episode psychosis; gray matter volume; psychosis risk; ultra-high risk; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; CEREBRAL-BLOOD-FLOW; ULTRA-HIGH RISK; PROGRESSIVE REDUCTION; CORTICAL THICKNESS; EPA GUIDANCE; SCHIZOPHRENIA; PREDICTION; BRAIN; ABNORMALITIES;
D O I
10.1017/S0033291720001282
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background Clinical high-risk (CHR) for psychosis is indicated by ultra-high risk (UHR) and basic symptom (BS) criteria; however, conversion rates are highest when both UHR and BS criteria are fulfilled (UHR&BS). While BSs are considered the most immediate expression of neurobiological aberrations underlying the development of psychosis, research on neurobiological correlates of BS is scarce. Methods We investigated gray matter volumes (GMV) of 20 regions of interest (ROI) previously associated with UHR criteria in 90 patients from the Bern early detection service: clinical controls (CC), first-episode psychosis (FEP), UHR, BS and UHR&BS. We expected lowest GMV in FEP and UHR&BS, and highest volume in CC with UHR and BS in-between. Results Significantly, lower GMV was detected in FEP and UHR&BS patients relative to CC with no other significant between-group differences. When ROIs were analyzed separately, seven showed a significant group effect (FDR corrected), with five (inferior parietal, medial orbitofrontal, lateral occipital, middle temporal, precuneus) showing significantly lower GM volume in the FEP and/or UHR&BS groups than in the CC group (Bonferroni corrected). In the CHR group, only COGDIS scores correlated negatively with cortical volumes. Conclusions This is the first study to demonstrate that patients who fulfill both UHR and BS criteria - a population that has been associated with higher conversion rates - exhibit more severe GMV reductions relative to those who satisfy BS or UHR criteria alone. This result was mediated by the BS in the UHR&BS group, as only the severity of BS was linked to GMV reductions.
引用
收藏
页码:2666 / 2674
页数:9
相关论文
共 50 条
  • [31] Most influential symptoms in the early detection of clinical high risk for psychosis in Indonesia: A basic symptom network
    Ambarini, Tri Kurniati
    Hartini, Nurul
    Surjaningrum, Endang
    Chusairi, Ahmad
    Arifianto, Dhany
    Syulthoni, Zain Budi
    Puspitasari, Irma Melyani
    Adiati, Rosatyani Puspita
    Schultze-Lutter, Frauke
    ASIAN JOURNAL OF PSYCHIATRY, 2025, 106
  • [32] Higher Body-Mass Index and Lower Gray Matter Volumes in First Episode of Psychosis
    Kolenic, Marian
    Spaniel, Filip
    Hlinka, Jaroslav
    Matejka, Martin
    Knytl, Pavel
    Sebela, Antonin
    Renka, Jiri
    Hajek, Tomas
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [33] White matter microstructure and the clinical risk for psychosis: A diffusion tensor imaging study of individuals with basic symptoms and at ultra-high risk
    Smigielski, Lukasz
    Stampfli, Philipp
    Wotruba, Diana
    Buechler, Roman
    Sommer, Stefan
    Gerstenberg, Miriam
    Theodoridou, Anastasia
    Walitza, Susanne
    Rossler, Wulf
    Heekeren, Karsten
    NEUROIMAGE-CLINICAL, 2022, 35
  • [34] Excessive interstitial free-water in cortical gray matter preceding accelerated volume changes in individuals at clinical high risk for psychosis
    Cho, Kang Ik K.
    Zhang, Fan
    Penzel, Nora
    Seitz-Holland, Johanna
    Tang, Yingying
    Zhang, Tianhong
    Xu, Lihua
    Li, Huijun
    Keshavan, Matcheri
    Whitfield-Gabrieli, Susan
    Niznikiewicz, Margaret
    Stone, William S.
    Wang, Jijun
    Shenton, Martha E.
    Pasternak, Ofer
    MOLECULAR PSYCHIATRY, 2024, 29 (11) : 3623 - 3634
  • [35] Heterogeneity of clinical symptomatology in pediatric patients at clinical high risk for psychosis
    Rintell, L. Sophia
    Carroll, Devon
    Wales, Meghan
    Gonzalez-Heydrich, Joseph
    D'Angelo, Eugene
    BMC RESEARCH NOTES, 2024, 17 (01)
  • [36] Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis
    DeVylder, J. E.
    Ben-David, S.
    Schobel, S. A.
    Kimhy, D.
    Malaspina, D.
    Corcoran, C. M.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (02) : 259 - 268
  • [37] Effects of age and sex on clinical high-risk for psychosis in the community
    Schultze-Lutter, Frauke
    Schimmelmann, Benno G.
    Fluckiger, Rahel
    Michel, Chantal
    WORLD JOURNAL OF PSYCHIATRY, 2020, 10 (05): : 101 - 124
  • [38] Neuroanatomical and Symptomatic Sex Differences in Individuals at Clinical High Risk for Psychosis
    Guma, Elisa
    Devenyi, Gabriel A.
    Malla, Ashok
    Shah, Jai
    Chakravarty, M. Mallar
    Pruessner, Marita
    FRONTIERS IN PSYCHIATRY, 2017, 8
  • [39] Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
    Davies, Cathy
    Paloyelis, Yannis
    Rutigliano, Grazia
    Cappucciati, Marco
    De Micheli, Andrea
    Ramella-Cravaro, Valentina
    Provenzani, Umberto
    Antoniades, Mathilde
    Modinos, Gemma
    Oliver, Dominic
    Stahl, Daniel
    Murguia, Silvia
    Zelaya, Fernando
    Allen, Paul
    Shergill, Sukhi
    Morrison, Paul
    Williams, Steve
    Taylor, David
    McGuire, Philip
    Fusar-Poli, Paolo
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (07) : 1300 - 1309
  • [40] Grey-matter abnormalities in clinical high-risk participants for psychosis
    Zikidi, Katia
    Gajwani, Ruchika
    Gross, Joachim
    Gumley, Andrew, I
    Lawrie, Stephen M.
    Schwannauer, Matthias
    Schultze-Lutter, Frauke
    Fracasso, Alessio
    Uhlhaas, Peter J.
    SCHIZOPHRENIA RESEARCH, 2020, 226 : 120 - 128